Jefferies Financial Group Inc. Abb Vie Inc. Put Options Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $583,044 - $725,560	4,400 Added 7.2%	65,500 $8.82 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $8.6 Million - $9.91 Million	-59,500 Reduced 49.34%	61,100 $9.74 Million
Q4 2022 Sep 21, 2023	BUY	$138.31 - $165.87 $7.62 Million - $9.14 Million	55,100 Added 84.12%	120,600 $19.5 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $16.7 Million - $20 Million	120,600 New	120,600 $19.5 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.